Skip to main content
Premium Trial:

Request an Annual Quote

CLC Bio Supplies Software to S. American 'Biodiversity' Database

NEW YORK (GenomeWeb News) — A South American effort to create a database of sequence data from the continent’s “vast biodiversity” will use CLC Bio’s software, data analysis tools, training, and other services, the company said today.
Under a commercial agreement, the Genomic Heritage and Local Wisdom project, or PGSL, will include universities and government agencies from all over South America to harvest and preserve genomic data from “ancient and traditional therapeutic healthcare substances,” the company said.
The PGSL also hopes to minimize "bio-piracy” or the problem of “non-native scientists harvesting and using genetic materials from South America for copyrighted products.”
At a recent meeting of many member agencies, CLC Bio vice president Jan Lomholdt said it is “vital to gain a deeper understanding of the unique species in Amazonia, Patagonia, and the Galápagos Islands,” among other regions.
He added that increasing knowledge of South American biodiversity is essential to “help increase the overall level of understanding of genetics and bioinformatics.”
Terms of the alliance were not disclosed.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.